Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-196-5 | CAS number: 92-84-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Jan. 1977 to Feb. 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well performed study prior to GLP meeting scientific principles and similar to previous OECD TG.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 977
- Report date:
- 1977
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: As outlined in "Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics" by the staff of the Division of Pharmacology, Food and Drug Administration, Department of Health, Education and Welfare, pages 17-25
- Deviations:
- not specified
- GLP compliance:
- no
- Remarks:
- Prior to GLP
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Phenothiazine
- EC Number:
- 202-196-5
- EC Name:
- Phenothiazine
- Cas Number:
- 92-84-2
- Molecular formula:
- C12H9NS
- IUPAC Name:
- 10H-phenothiazine
- Details on test material:
- - Name: Phenothiazine Purified
- Lot No. NB-36-145
- Phenothiazine Content 99.8%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Albino rats (Sprague Dawley strain) obtained fromSasco, Inc., Omaha, Nebraska. (U.S.D.A. License No. 47-A-B-98).
- Animals were 40-50 days of age.
- Animals are examined upon receipt to check for any apparent abnormal condition.
- Any animal which did not appear to be normal was discarded.
- Animals were then transferred to individual cages in a temperature controlled room where they acclimated for seven days prior to initiation of the study.
- Animals werde maintained in individual cages throughout the study period.
- Purina Rat Chow and clean water was provided for each animal on an ad libitum basis throughout the study period except that they are fasted twenty-four hours prior to administration of the test compounds.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- cotton seed oil
- Doses:
- - Dose-range-findings study: 2000 - 3170 - 5024 - 7964 - 12623 - (1257 - 1992) mg/kg
- Main study: Five Dose Level Study (0.1 log intervals) 600 - 755 - 951 - 1197 - 1508 mg/kg - No. of animals per sex per dose:
- 1 male and 1 female in range-finding-study (1257 mg/kg in 1 male - 1992 mg/kg in 1 female)
5 males and 5 females per dose in main study - Control animals:
- no
- Details on study design:
- Duration of observation period following administration:
- 14 days
Frequency of observations and weighing:
- Each animal was observed by trained technicians at approx. two hour intervals during the first working day following adminstration of the test compound.
- Thereafter, observations were made two or three times each day for the remainder of the study.
- Animals were observed for any visual sign of weakness, abnormal breathing or abnormal body movement.
- Further, if animals appeared unconscious, they were removed from their cage, checked for any abdominal distention, oral and anal areas were examined for any change and they were tested for response to stimulus (noise and prodding) - Statistics:
- - Method of Litchfield-Wilcoxon was applied
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 370 mg/kg bw
- 95% CL:
- > 1 223 - <= 1 534
- Mortality:
- Please see table "Mortalitiy Data of Main Study" in section "Remarks on results including tables and figures" below
- Clinical signs:
- other: Please see section "Remarks on results including tables and figures" below for details.
- Gross pathology:
- Data only on dose-range finding study, please see section "Remarks on results including tables and figures" below for details. No gross pathology performed in main study due to the results of the dose-range-finding-study.
- Other findings:
- Please see section "Remarks on results including tables and figures" below for details.
Any other information on results incl. tables
RESULTS OF MAIN STUDY
Animals in treatment groups 600, 755 and 951 mg/kg were slightly weak through the first eight hours following intubation. Animals in treatment groups 1197 and 1508 mg/kg were semi-conscious through the first eight hours. Animals in the lowest dosage groups which survived were weak through the first six or seven days of the study before returning to normal. Animals in the two highest dosage groups, which survived, remained weak throughout the fourteen day study period. All animals had varying degrees of diarrhoea.
Table: Mortality Data of Main Study
Rat No. and Sex | Dosage mg/kg | Mortality |
5 male and 5 female | 600 | 1 male found dead the morning of 6th study day |
5 male and 5 female | 755 | 1 male found dead the morning of 3rd study day |
5 male and 5 female | 951 | 1 female found dead the morning of 2nd study day |
5 male and 5 female | 1197 | 1 male found dead the morning of 3rd study day and 1 male found dead the morning of 4th study day |
5 male and 5 female | 1508 | 1 male and 1 female found dead the morning of 2nd study day; 1 male and 1 female found dead the morning of 3rd study day; 1 male and 1 female found dead the morning of 4th study day |
RESULTS OF DOSE-RANGE-FINDING-STUDY
Within one hour after intubation all animals were semi-conscious. Breathing appeared to be normal. Faecal material indicated the animals had some diarrhoea. Post mortem examination revealed all organs to be normal in size and color except for the stomach. The stomach was filled with the test material and the blood vessels of the intestinal tract appeared to be injected. All animals treated died, except for the single male rat which was tested at a dose of 1257 mg/kg body weight.
Applicant's summary and conclusion
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Based on the data obtained and under the conditions this study was conducted, the LD50 of Phenothiazine Purified (Lot No. NB 36-145) is 1370 mg per kilogram body weight as calculated by Litchfield-Wilcoxon Statistical Method. The 95% confidence interval is 1223 to 1534 mg per Kg.
- Executive summary:
Acute oral toxicity of phenothiazine was assessed in the present study. Animals in treatment groups 600, 755 and 951 mg/kg were slightly weak through the first eight hours following intubation. Animals in treatment groups 1197 and 1508 mg/kg were semi-conscious through the first eight hours. Animals in the lowest dosage groups which survived were weak through the first six or seven days of the study before returning to normal. Animals in the two highest dosage groups, which survived, remained weak throughout the fourteen day study period. All animals had varying degrees of diarrhoea.
Based on the data obtained and under the conditions this study was conducted, the LD50 of Phenothiazine Purified (Lot No. NB 36-145) is 1370 mg per kilogram body weight as calculated by Litchfield-Wilcoxon Statistical Method. The 95% confidence interval is 1223 to 1534 mg per kg. Classification according to 67/548/EEC phenothiazine is harmful, classification according to Regulation (EC) 1272/2008 would be Acute Toxicity Category 4 with H302.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)